Nelson Hardiman managing partner Harry Nelson presented at the 13th Annual Family Office Investment Symposium where he discussed the four main buckets of potential life sciences investing, including 1) pharma/biotech, 2) medical devices, 3) neutraceuticals, supplements, and cosmeceuticals, and 4) clinical research and technology transfer.
Posted on February 27, 2018
Recent Posts
Reproductive Rights Attorney: This Is Why Right-Wing Interest Are Attempting To Ban MifepristoneHarry Nelson on Forbes News: Impact of the Alabama Supreme Court’s Frozen Embryo RulingCalifornia’s Corporate Healthcare Law, Practice of Medicine (CPOM)Harry Nelson interviewed regarding asthma inhaler switch coming in JanuaryImplications of California’s New Reproductive Healthcare Laws for Providers